RJFSA
INFI

Raymond James Financial Services Advisors’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

Raymond James Financial Services Advisors’s Portfolio INFI Stock Details INFI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-11,725
Closed -$12K – 2965
2019
Q3 		$12K Hold
11,725
– – ﹤0.01% 2770
2019
Q2 		$21K Hold
11,725
– – ﹤0.01% 2788
2019
Q1 		$22K Sell
11,725
-25
-0.2% -$37 ﹤0.01% 2748
2018
Q4 		$14K Buy
+11,750
New +$21.1K ﹤0.01% 2529

Other funds holding INFI

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Raymond James Financial Services Advisors's INFI Position: Q4 2019 in Review

Raymond James Financial Services Advisors sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q4 2019, closing a stake of 11,725 shares — an estimated $12K sold.

Raymond James Financial Services Advisors first reported a position in INFI in Q4 2018 and held it in 4 quarters. The position peaked at $22K in Q1 2019. 47 funds tracked by Wall St. Rank hold INFI as of Q4 2019.

  • Raymond James Financial Services Advisors reported no remaining Infinity Pharmaceuticals, Inc. position as of Q4 2019 after selling out during the quarter.
  • Raymond James Financial Services Advisors sold 11,725 Infinity Pharmaceuticals, Inc. shares in Q4 2019, an estimated $12K.
  • Raymond James Financial Services Advisors first reported a position in Infinity Pharmaceuticals, Inc. in Q4 2018 and held it in 4 quarters.
  • Raymond James Financial Services Advisors's Infinity Pharmaceuticals, Inc. position peaked at $22K in Q1 2019.
  • 47 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q4 2019.

Based on Raymond James Financial Services Advisors's 13F filing for Q4 2019, filed 12 Feb 2020.